Aurobindo Pharma has the highest US generics sales compared to any other listed company in India, with a maximum number of ANDA approvals.

(Representative image. Photo source: Unsplash) Product development, as well as backward integration for the manufacturing process, has enabled Aurobindo Pharma's healthy profitability despite consistent price erosion (albeit at reduced intensity).

To continue reading this story You must be an existing Premium User Already a Premium User? Sign In

See Full Page